BRBalqees Mohammed M. Rawashdeh

Balqees Mohammed M. Rawashdeh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Balqees Mohammed M. Rawashdeh has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    MTHFR C677T and A1298C polymorphisms and their association with ischemic stroke in populations from five Middle Eastern countries: a systematic review and meta-analysis

    by Abdulrhman H. M. Muhaisen, Balqees Mohammed M. Rawashdeh, Wejdan Y. Alquran

    Background: Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms have been investigated in relation to ischemic stroke, but findings vary across populations and genetic models. Evidence from Middle Eastern countries remains geographically limited and should not be interpreted as representing a homogeneous genetic population. Objective: To systematically evaluate the association of MTHFR C677T and A1298C polymorphisms with ischemic stroke in populations from Middle Eastern countries represented in the available evidence. Methods: PubMed/MEDLINE, Scopus, and Web of Science Core Collection were searched from inception through October 2, 2026. Eligible studies were original human observational genetic-association studies reporting MTHFR C677T and/or A1298C data in ischemic stroke or cerebral infarction cases and controls. Primary quantitative analyses were restricted to adult datasets with directly extractable genotype or allele counts. Random-effects odds ratios (ORs) were pooled using inverse-variance weighting with restricted maximum-likelihood estimation of between-study variance. Allele, dominant, recessive, homozygous, and heterozygous contrasts were evaluated as correlated genetic models. Heterogeneity was assessed using I² and τ², and 95% prediction intervals were calculated. Hartung–Knapp confidence intervals and Hardy–Weinberg equilibrium-restricted, leave-one-out, sparse-data, and study-specific sensitivity analyses were performed. Pediatric evidence was analyzed separately as secondary evidence. Results: Seventeen reports from Turkey, Iran, Egypt, Iraq, and Saudi Arabia were included in the qualitative synthesis. Nine independent adult datasets contributed to the primary C677T analysis (916 cases and 1396 controls), and six contributed to the A1298C analysis (862 cases and 1121 controls). For C677T, conventional random-effects confidence intervals were above the null for the allele (OR 1.49, 95% CI 1.18–1.87), dominant (1.69, 1.08–2.64), recessive (1.76, 1.27–2.43), and homozygous (2.35, 1.41–3.92) contrasts, whereas the heterozygous comparison was imprecise (1.58, 0.99–2.53). Hartung–Knapp confidence intervals remained above the null only for the allele, recessive, and homozygous C677T contrasts. For A1298C, conventional random-effects confidence intervals were above the null for the allele, dominant, recessive, and homozygous contrasts, whereas Hartung–Knapp intervals remained above the null only for the allele and homozygous comparisons. Substantial heterogeneity and wide prediction intervals limited the generalizability of several model-specific estimates. Conclusion: The available adult evidence suggests model-dependent associations between MTHFR C677T and A1298C polymorphisms and ischemic stroke in the represented populations. For C677T, the allele, recessive, and homozygous comparisons showed comparatively greater consistency across conventional random-effects and Hartung–Knapp analyses. For A1298C, the allele and homozygous comparisons showed comparatively more consistent statistical evidence. However, the limited number of datasets, heterogeneity, potential population stratification, and study-level methodological limitations warrant cautious interpretation. These unadjusted associations do not establish causality or clinical predictive utility.

  • Open Access

    Relatively preserved cognition despite elevated adjusted serum neurofilament light in U.S. adults aged 60–75 years: a survey-weighted NHANES analysis

    by Abdulrhman H. M. Muhaisen, Balqees Mohammed M. Rawashdeh

    Background: Studies of circulating neurofilament light chain (NfL) and cognition have predominantly examined population-average associations, leaving individuals with relatively preserved cognition despite elevated biomarker burden insufficiently characterized. We investigated whether educational, socioeconomic, and behavioral resources were associated with this NfL–cognition discordance phenotype in older adults. Methods: We conducted a cross-sectional complex-survey analysis of participants aged 60–75 years in the 2013–2014 National Health and Nutrition Examination Survey (NHANES). The primary analytic cohort included 502 participants with valid serum NfL measurements and complete cognitive assessments. Serum NfL was adjusted for age, sex, and estimated glomerular filtration rate, whereas global cognition was adjusted for age, sex, and test language. Participants were classified into four joint NfL–cognition phenotypes, with the primary analysis comparing participants with relatively preserved-cognition discordance against those with concordant impairment among individuals with elevated adjusted NfL. Survey-weighted regression models incorporated multiple imputation and prespecified robustness analyses. Results: The weighted proportion meeting the study-defined criteria for relatively preserved-cognition discordance was 16.3% (95% CI, 12.0%–21.4%), whereas 8.9% (95% CI, 5.5%–13.6%) met the criteria for concordant impairment. These proportions are conditional on the internally defined NfL and cognition thresholds and should not be interpreted as clinical prevalence estimates. Among participants with elevated adjusted NfL, educational attainment was the only candidate correlate associated with relatively preserved cognition in the primary categorical analysis (overall p = 0.010). Compared with less than high school education, the odds of relatively preserved cognition increased across higher educational categories, whereas poverty-income ratio and recreational physical activity were not associated with the categorical phenotype. In complementary continuous analyses, education, poverty-income ratio, and physical activity were associated with better-than-expected cognition. Higher adjusted NfL showed a generally inverse pattern across cognitive outcomes, with the clearest evidence for global cognition (β=−0.117; 95% CI, − 0.206 to − 0.028) and Digit Symbol Substitution Test (DSST) performance (β=−0.086; 95% CI, − 0.172 to − 0.001). Findings were generally consistent across most stable prespecified sensitivity analyses, alternative cognitive definitions, inverse-probability weighting, and leave-one-primary-sampling-unit-out analyses, although evidence was attenuated under some alternative threshold definitions. Conclusions: Among U.S. adults aged 60–75 years with elevated adjusted serum NfL in the NHANES serum-NfL subsample, cognitive performance was heterogeneous. Educational attainment was the most consistent correlate of relatively preserved-cognition discordance, although the data did not show that education modified the association between NfL and cognition. Joint consideration of biomarker burden and cognitive performance may provide complementary information beyond evaluating either measure alone. The phenotype framework should presently be regarded as an analytical research approach rather than a clinically deployable classification system, and longitudinal validation in independent cohorts is required.

  • Open Access

    ACE insertion/deletion polymorphism and ischemic stroke susceptibility among populations from Turkey, Egypt, Iran, and Iraq: a systematic review and meta-analysis

    by Abdulrhman H. M. Muhaisen, Balqees Mohammed M. Rawashdeh

    Background: Ischemic stroke is a major cause of mortality and long-term neurological disability worldwide. Although conventional vascular risk factors explain a substantial proportion of ischemic stroke burden, genetic susceptibility may contribute to inter-individual and population-level differences in risk. The angiotensin-converting enzyme insertion/deletion (ACE I/D) polymorphism is a biologically plausible vascular candidate variant because of its relationship with ACE activity, renin-angiotensin system regulation, endothelial function, vascular remodeling, and blood-pressure control. However, findings from Middle Eastern populations remain inconsistent. Objective: To systematically evaluate and quantitatively synthesize the association between ACE I/D polymorphism and ischemic stroke susceptibility in populations from the Middle East, with inferences restricted to the countries represented in the eligible evidence—Turkey, Egypt, Iran, and Iraq. Methods: This PRISMA 2020–based systematic review and meta-analysis was prospectively registered in PROSPERO (CRD420261406483). PubMed/MEDLINE, Scopus, and Web of Science were searched from inception to May 23, 2026 for observational genetic association studies reporting ACE I/D genotype or allele data in ischemic stroke cases and stroke-free Middle Eastern controls. Two reviewers independently conducted study selection, data extraction, and Newcastle-Ottawa Scale quality assessment. Random-effects ORs with 95% CIs were pooled under allele, dominant, recessive, homozygous, and heterozygous models, with sensitivity analyses excluding studies with HWE deviation, reconstructed counts, historical controls, and other strict-quality concerns. Results: Ten studies including 1,317 ischemic stroke cases and 979 controls were included, representing Turkey, Egypt, Iran, and Iraq. Across all primary random-effects models, ACE I/D polymorphism was not significantly associated with ischemic stroke susceptibility. The pooled estimates were: allele contrast D vs. I, OR = 1.16 (95% CI: 0.97–1.38); dominant model DD + ID vs. II, OR = 1.20 (95% CI: 0.91–1.57); recessive model DD vs. ID + II, OR = 1.20 (95% CI: 0.89–1.61); homozygous model DD vs. II, OR = 1.26 (95% CI: 0.94–1.70); and heterozygous model ID vs. II, OR = 1.14 (95% CI: 0.84–1.55). Heterogeneity ranged from low to moderate across most models, with the highest heterogeneity observed in the recessive model. Sensitivity analyses, particularly the exclusion of two studies with control-group Hardy–Weinberg equilibrium deviation, consistently attenuated the pooled estimates toward the null and did not support a robust association. Conclusion: Available evidence does not demonstrate a statistically robust association between ACE I/D polymorphism and ischemic stroke susceptibility in the populations studied in Turkey, Egypt, Iran, and Iraq. Although D-allele and DD-genotype carriers showed a weak non-significant trend toward increased risk, this pattern was not stable under sensitivity analyses. Given the null pooled findings, modest evidence base, predominance of unadjusted genotype-derived estimates, and absence of reliable stroke subtype-specific data, the current evidence does not support ACE I/D genotyping for clinical ischemic stroke risk prediction. These findings should not be generalized to Middle Eastern countries for which eligible evidence was unavailable.


  • Open Access

    What is the association between the MTHFR C677T polymorphism and migraine susceptibility among populations in the Middle East? A systematic review

    by Abdulrhman H. M. Muhaisen, Ossama M. AbuSuailik, Balqees Mohammed M. Rawashdeh, Rawan Tayseer Aljohar, Bielasan Mohammad Khlefat, Lorans Al-Sharadqah, Hasan M. H. Muhaisen, Sufian Abuashabh, Sara Dhaher

    Background: Migraine is a common multifactorial neurovascular disorder with a substantial genetic component. The methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism has been implicated in migraine susceptibility, particularly migraine with aura, through its effects on folate metabolism and homocysteine regulation. However, findings remain inconsistent across populations, and evidence from the Middle East is limited. Objective: To systematically evaluate the association between the MTHFR C677T polymorphism and migraine susceptibility among populations from countries represented in the eligible evidence (Turkey, Iran, Egypt). Methods: A systematic review was conducted in accordance with PRISMA 2020 guidelines and prospectively registered in PROSPERO (CRD420251164175). Electronic databases (PubMed, PMC, and DOAJ) were searched up to October 9, 2025. Eligible studies included case–control investigations assessing MTHFR C677T polymorphism in migraine patients and controls from countries represented in the eligible evidence (Turkey, Iran, Egypt). Findings were synthesized narratively due to heterogeneity in study design, populations, and outcome reporting. Study quality was assessed using the Newcastle–Ottawa Scale. Results: Six case–control studies comprising 793 migraine patients and 848 controls met the inclusion criteria. Most included studies reported a significant association between the MTHFR C677T polymorphism and increased migraine susceptibility, particularly among individuals carrying the TT genotype. The association was more consistently observed in migraine with aura compared to migraine without aura, although several studies also reported a relationship with migraine without aura. One study did not find a significant overall association. Evidence regarding other MTHFR variants, including A1298C and rs4846049, was limited and inconsistent across studies. Conclusion: This systematic review suggests a consistent association between the MTHFR C677T polymorphism, particularly the TT genotype, and migraine susceptibility in populations from countries represented in the eligible evidence (Turkey, Iran, Egypt). Several included studies indicate a stronger relationship with migraine with aura, supporting the potential involvement of MTHFR-related metabolic pathways in migraine pathophysiology. The observed patterns highlight the possible influence of regional genetic and environmental factors; however, the absence of quantitative synthesis limits the ability to estimate pooled effect sizes.